Clinical Trial Update: A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating and comparing the pharmacokinetic and pharmacodynamic profiles of sitagliptin, saxagliptin, and vildagliptin in participants with Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)
• Januvia (sitagliptin)
• Onglyza (Saxagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2014-01-22